Die mangelnde Wasserlöslichkeit von Wirkstoffen ist eines der größten Probleme in der pharmazeutischen Medikamentenentwicklung, welches durch das Scheitern zahlloser vielversprechender Leitstrukturen immense Kosten verursacht. Es wird eine Methode vorgestellt, um spezifische Löslichkeitsvermittler für schwerlösliche, niedermolekulare Verbindungen zu entwickeln. Dafür wurden Partner für die nichtkovalente Bindung von Wirkstoffen aus Peptidbibliotheken identifiziert. Als Testsubstanzen wurden Sensibilisatoren für die photodynamische Krebstherapie gewählt. Über die Fluoreszenz der Photosensibilisatoren konnte die Anreicherung an Polymerpartikeln verfolgt werden, deren Peptidsequenzen eine hohe Affinität zu den Wirkstoffen besaßen. Positive Treffer wurden isoliert und deren Aminosäuresequenz mittels Tandem-Massenspektrometrie bestimmt. Diese Informationen wurden verwendet, um Löslichkeitsvermittler für die Sensibilisatoren zu synthetisieren. Dafür wurden die Sequenzen an einen hydrophilen Polyethylenoxid-Block (PEO) konjugiert, wobei das Peptidsegment die Bindung des Gastmoleküls vermittelt, während der Polymerblock die Wasserlöslichkeit des Komplexes garantiert. Mit diesen Konjugaten wurden die Sensibilisatoren erfolgreich in wässrige Lösung gebracht. Die Eigenschaften der Solubilisatoren bezüglich Beladungsgrad, Aggregation und Freisetzung der Gastmoleküle wurde untersucht, sowie die Aktivität der solubilisierten Sensibilisatoren bezüglich der Erzeugung von Singulett-Sauerstoff. Die Anpassung der Screening-Bedingungen, der Konjugat-Architektur und den Einbau eines schaltbaren Bausteins erlaubte die zusätzlich Feinjustierung. Durch einen Vergleich der verschiedenen Sensibilisatoren wurde die Sensibilität der Methode für strukturelle Unterschiede der Testsubstanzen und die Spezifität der gewonnenen Solubilisatoren für ihr Zielmolekül überprüft. Zuletzt wurden die Aufnahme und der Aufnahmemechanismus der solubilisierten Sensibilisatoren in Krebszellen studiert. / Insufficient water solubility of small molecule compounds is one of the major issues in pharmaceutical drug development causing tremendous costs due to failure of numerous high potential lead structures. Herein, a generic method to develop specific solubilizers for insoluble, small molecules is presented. Suitable binding partners for a set of sensitizers for photodynamic cancer therapy (m THPC, Pheophorbide A und Chlorin E6) were selected from a split&mix peptide library. The enrichment of sensitizer molecules at high affinity peptide sequences was followed by monitoring their intrinsic fluorescence via fluorescence microscopy. Positive hits were isolated and amino acid sequences were identified by tandem mass spectrometry (MALDI-Tof-MS/MS). The information gained about the requirement for non-covalent binding on a molecular level was used to synthesize specific solubilizers for small molecule drug entities. Therefore, identified peptide sequences were conjugated to a polyethylene oxide block to obtain water solubility, whereas peptide segments provide non-covalent binding of drug molecules. Insoluble photosensitizers were successfully rendered water soluble by peptide-PEO conjugates. Key parameters like drug payload capacity, aggregation behavior and guest molecule release, as well as activity regarding singlet oxygen generation, were studied. By adaptation and variation of screening conditions, conjugate architecture and incorporation of a switchable building block, properties of conjugate solubilizers were fine-tuned further. To evaluate screening sensitivity towards structural aspects of screened small molecules and specify of resulting solubilizers, screening results of different sensitizers and peptide-PEO solubilizers performance were compared. Finally, cellular uptake of solubilized photosensitizer in cancer cells and uptake pathways was studied in vitro using confocal laser-scanning microscopy and fluorescence lifetime imaging.

Este trabalho tem como finalidade obter condições de recuperar e purificar a pró-toxina épsilon e uma protease produzida pelo Clostridium perfringens através do uso da técnica de extração líquido-líquido em sistema de duas fases aquosas (SDFA) para utilização na produção de vacinas. A aplicação do sistema de duas fases aquosas é proposta como alternativa para a purificação, pois permite a separação e análise de partículas biológicas. Esta técnica é aconselhável para purificação em larga escala pela possibilidade de partição seletiva com altos rendimentos, além de apresentar uma boa relação custo-benefício. Foram construídas as curvas binodais que foram utilizadas para análise da composição dos sistemas de duas fases aquosas formados por polietileno glicol e citrato de sódio, como também a extração e recuperação da pró-toxina épsilon e da protease produzidas por Clostridium perfringens. As curvas binodais foram construídas utilizando PEG 400, 550, 1000, 1500, 3350 e 8000 em diferentes valores de pH (6,0; 6,5; 7,0; 7,5 e 8,0) e água para formação do sistema. Também foram construídas curvas na presença de caldo clarificado em substituição à água. Foi avaliada ainda a estabilidade da pró-toxina épsilon, antes da extração, e da protease antes e após a extração, frente às variações de pH e temperatura. Um planejamento experimental ('2pot.8-3') foi usado para avaliar a influência das variáveis concentração e massa molar do PEG, concentração de citrato, pH, concentração de NaCl, fator de diluição do extrato, temperatura e massa total do sistema na extração da pró-toxina épsilon. A partição de uma protease presente no meio fermentado de C. perfringens foi estudada através do uso de três planejamentos experimentais completos (dois do tipo '2pot.4' e um do tipo '2pot.3') que avaliaram a influência das variáveis concentração e massa molar do PEG, concentração de citrato e pH. Três variáveis-resposta foram obtidas (aumento de pureza, coeficiente de partição e recuperação da enzima). Os resultados atingidos foram: coeficiente de partição de 0,57, aumento de pureza de 4,2 com uma recuperação de 131% da atividade enzimática na fase superior do sistema. O sistema de extração que proporcionou as melhores condições de extração foi constituído por: PEG 10000 (g/mol) e concentração de 22% (m/m), concentração de citrato de 8% (m/m) e pH 8,5. A protease permaneceu estável (durante 48 h), mesmo após a extração, nas temperaturas de 5°C e 25°C e nos valores de pH de 6,0 a 9,0. / The purpose of this work is to obtain best conditions of recovery and purification of proteins (epsilon prototoxin and a protease) produced by Clostridium perfringens through the use of the liquid-liquid extraction by aqueous two-phases systems (ATPS). The application of these systems is proposed as alternative for protein purification, because it allows the separation and analysis of biological particles. This technique is advisable process purification applied to large scale since it provides a selective partition with high yields, and good cost-benefit ratio. The binodal curves were constructed and used to determine the system composition based on polyethylene glicol and citrate concentrations. The binodal curves were built by using PEG 400, 550, 1000, 1500, 3350 and 8000 g/mol at different pH values (6.0; 6.5; 7.0; 7.5 and 8.0). The curves were, initially, built in the presence of water and, later, with clarified fermented broth. The differences in the curve profiles (water versus broth) helped to explain the phase separation behaviour. The stability, as a function of pH and temperature, of the epsilon prototoxin was evaluated before the extraction, while the stability of the protease was evaluated before and after the extraction. An experimental design ('2pot.8-3') was used to evaluate the influence of the following variables on epsilon prototoxin extraction: concentration and molar mass of PEG, citrate concentration and NaCl concentrations, pH, dilution factor of the extract, temperature and total mass of the system. However, the partition of the protease was studied through the use of the three full different experimental designs (two of the type '2pot.4', and one of the type '2pot.3') that evaluated the influence of the following variables: concentration and molar mass of PEG, citrate concentration and pH. Three parameter responses were obtained: purification factor; coefficient partition; and recovery yield of the enzyme. The results were satisfactory: partition coefficient = 0.57, purification factor = 4.2; yield = 131%. The extraction conditions which provided the best results were: molar mass of PEG 10000 (g/mol); concentration of PEG of 22% (w/w); concentration of citrate of 8% (w/w); and pH 8.5. The protease was stable (during 48h), even after the extraction, in the temperatures of 5°C and 25°C, and at pH values of from 6.0 to 9.0.

Dans le but de réduire l’utilisation des solvants organiques dans les réactions et dans la purification, nous avons envisagé de coupler la synthèse supportée sur PEGs dans l’eau aux microréacteurs en flux continu et à l’ultrafiltration comme technique de purification. Dans un premier temps nous avons synthétisé des 3,4-dihydropyrimidin-2-ones (DHPMs) en utilisant comme étape clef la réaction multicomposant de Biginelli avec un aldéhyde supporté sur PEG. Dans ce but, nous avons trouvé que la liaison du PEG au 4-carboxybenzaldehyde, décrite dans le CH2Cl2, a lieu dans le PEG fondu (70 °C) en absence de solvant. La synthèse des DMPMs a ensuite été réalisée dans l’eau et dans le PEG fondu, à partir de l’aldéhyde supporté, et les produits finaux ont été isolés après saponification. Cette synthèse a ensuite été optimisée en microréacteurs en flux continu dans l’eau et la purification des adduits supportés a été réalisée par ultrafiltration dans l’eau.La stratégie décrite ci-dessus a été appliquée à des synthèses multi-étapes, la réaction de Baylis-Hillmann étant l’étape clef pour la préparation de tétrahydro-1,3-oxazine, tétrazoles, 1,4-oxazepin-3-ones et tétrahydro-1,3-pyrimidin-4-ones, composés dotés d'une activité biologique potentielle. Les synthèses de tétrahydro-1,3-oxazines et d’un tétrazole ont d’abord été optimisées par lots avec les purifications réalisées par ultrafiltration dans l’eau, puis adaptées en microréacteurs en flux continu.Tous les adduits supportés sur PEG ont été caractérisés par RMN et MALDI-Tof, et des nouvelles méthodes d’analyse RMN ont été mises au point afin de réduire l’intensité des signaux dus au PEG et de faciliter l’étude des molécules supportées.En conclusion nous avons développé la synthèse supportée, en milieux éco-compatibles de DHPMs, tétrahydro-1,3-oxazines et d’un tétrazole, par lots et en microréacteurs en flux continu, en utilisant les réactions de Biginelli et Baylis-Hillmann comme étapes clefs. Toutes les purifications ont été réalisées par ultrafiltration dans l’eau, afin de réduire l’utilisation de solvants organiques. / Aiming to avoid the use of volatile organic solvents in both the reaction and the separation steps, we envisioned to couple the use of PEGs as support to continuous flow chemistry and ultrafiltration in water as separation technique. First, we synthesized 3,4-dihydropyrimidin-2-(1H)-ones (DHPMs) exploiting the Biginelli multicomponent reaction starting from PEG-supported aldehyde. For this purpose, we found that the linkage of 4-carboxybenzaldehyde to PEG4000, described in the literature to occur in CH2Cl2, takes place in melted PEGs (70 °C) in the absence of solvent. We developed a novel organic solvent free synthesis of DHPMs via the Biginelli reaction of PEG-supported aldehyde, and we isolate the final products via saponification. Then, the same Biginelli reaction was carried out in continuous flow micro-reactor using water as the solvent and the supported products were isolated by ultrafiltration.The above mentioned strategy was also applied to multistep syntheses, the Baylis-Hillman reaction being the key-step for the preparation of tetrahydro-1,3-oxazine, tetrazoles, 1,4-oxazepin-3-ones, and tetrahydro-1,3-pyrimidin-4-ones, compounds endowed with potential biological activity. The preparations of tetrahydro-1,3-oxazines and tetrazole were first optimized in batch with the purifications performed by ultrafiltration in water, then adapted to the continuous flow micro-reactor synthesis.All PEG-supported compounds were characterized by NMR and MALDI-TOF MS spectrometry. Moreover, in order to facilitate the analysis of PEG-supported product, we developed new NMR methods that help to reduce the intensity of PEG signals.In conclusion, we performed the PEG-supported organic solvent-free synthesis of DHPMs, tetrahydro-1,3-oxazines, and a tetrazole derivative, in batch as well as in continuous flow microreactor, using Biginelli and Baylis-Hillman reactions as key steps. All purifications were carried out by ultrafiltration in water, to avoid the use of organic solvents.

Les copolymères à blocs amphiphiles Polyéthylène-b-Polyéthylène glycol comportent un bloc hydrophile et un bloc hydrophobe, tous deux cristallisables. L’intérêt de cette thèse est de mieux comprendre le comportement de ces copolymères aux interfaces solides et liquides, via l’étude de la structure et de l’organisation des couches adsorbées. Des copolymères PE-b-PEG de différentes compositions ont été étudiés à l’état massique, mettant en évidence que le ratio PEG/PE ainsi que la longueur des blocs jouent un rôle significatif sur le taux de cristallinité, la morphologie et la croissance des structures cristallines. La caractérisation en films minces par spectroscopie PM-IRRAS et AFM a permis de déterminer quantitativement l’orientation des chaînes macromoléculaires de chaque bloc sur des substrats modèles hydrophiles et hydrophobes. L’adsorption des copolymères PE-b-PEG a par ailleurs été étudiée aux interfaces eau/air et eau/hexane par les méthodes de la goutte pendante et de la goutte oscillante. Les résultats, appuyés par des mesures de tailles de particules, ont montré que les copolymères sont capables de former des structures sphériques organisées à l’échelle nanométrique. L’influence de la composition du copolymère et de la nature des interfaces sur l’organisation des copolymères a ainsi permis d’élaborer des modèles d’adsorption des blocs aux interfaces. / Polyethylene-b-Polyethylene amphiphilic diblock copolymers are composed of one hydrophilic and one hydrophobic block, both able to crystallize. The aim of this thesis is to better understand the behaviour of PE-b-PEG copolymers at solid and liquid interfaces, via the study of the structure and the organization of adsorbed layers. The crystallinity of bulk PE-b-PEG copolymers with different composition was characterized, revealing that the ratio PEG/PE and the blocks length impact the crystallinity degree, the morphology and the growth of crystalline structures. Thin films characterization by PM-IRRAS spectrocopy and AFM allowed to determine quantitatively the macromolecular chains orientation on hydrophobic and hydrophilic substrates. PE-b-PEG copolymers adsorption at the water/air and water/hexane interfaces was studied thanks to the pendant drop and the oscillating drop techniques. These results, supported by particle size analysis, revealed that copolymers can organize as nanometric spherical structures. The influence of the copolymer composition and the type of interfaces on the organization then lead to the elaboration of adsorption models of PE and PEG blocks at solid and liquid interfaces.

Les nanoparticules polymériques biodégradable (NPs) sont apparues ces dernières années comme des systèmes prometteurs pour le ciblage et la libération contrôlée de médicaments. La première partie de cette étude visait à développer des NPs biodégradables préparées à partir de copolymères fonctionnalisés de l’acide lactique (poly (D,L)lactide ou PLA). Les polymères ont été étudiés comme systèmes de libération de médicaments dans le but d'améliorer les performances des NPs de PLA conventionnelles. L'effet de la fonctionnalisation du PLA par insertion de groupements chimiques dans la chaîne du polymère sur les propriétés physico-chimiques des NPs a été étudié. En outre, l'effet de l'architecture du polymère (mode d'organisation des chaînes de polymère dans le copolymère obtenu) sur divers aspects de l’administration de médicament a également été étudié. Pour atteindre ces objectifs, divers copolymères à base de PLA ont été synthétisés. Plus précisément il s’agit de 1) copolymères du poly (éthylène glycol) (PEG) greffées sur la chaîne de PLA à 2.5% et 7% mol. / mol. de monomères d'acide lactique (PEG2.5%-g-PLA et PEG7%-g-PLA, respectivement), 2) des groupements d’acide palmitique greffés sur le squelette de PLA à une densité de greffage de 2,5% (palmitique acid2.5%-g-PLA), 3) de copolymère « multibloc » de PLA et de PEG, (PLA-PEG-PLA)n. Dans la deuxième partie, l'effet des différentes densités de greffage sur les propriétés des NPs de PEG-g-PLA (propriétés physico-chimiques et biologiques) a été étudié pour déterminer la densité optimale de greffage PEG nécessaire pour développer la furtivité (« long circulating NPs »). Enfin, les copolymères de PLA fonctionnalisé avec du PEG ayant montré les résultats les plus satisfaisants en regard des divers aspects d’administration de médicaments, (tels que taille et de distribution de taille, charge de surface, chargement de drogue, libération contrôlée de médicaments) ont été sélectionnés pour l'encapsulation de l'itraconazole (ITZ). Le but est dans ce cas d’améliorer sa solubilité dans l'eau, sa biodisponibilité et donc son activité antifongique. Les NPs ont d'abord été préparées à partir de copolymères fonctionnalisés de PLA, puis ensuite analysés pour leurs paramètres physico-chimiques majeurs tels que l'efficacité d'encapsulation, la taille et distribution de taille, la charge de surface, les propriétés thermiques, la chimie de surface, le pourcentage de poly (alcool vinylique) (PVA) adsorbé à la surface, et le profil de libération de médicament. L'analyse de la chimie de surface par la spectroscopie de photoélectrons rayon X (XPS) et la microscopie à force atomique (AFM) ont été utilisés pour étudier l'organisation des chaînes de copolymère dans la formulation des NPs. De manière générale, les copolymères de PLA fonctionnalisés avec le PEG ont montré une amélioration du comportement de libération de médicaments en termes de taille et distribution de taille étroite, d’amélioration de l'efficacité de chargement, de diminution de l'adsorption des protéines plasmatiques sur leurs surfaces, de diminution de l’internalisation par les cellules de type macrophages, et enfin une meilleure activité antifongique des NPs chargées avec ITZ. En ce qui concerne l'analyse de la chimie de surface, l'imagerie de phase en AFM et les résultats de l’XPS ont montré la possibilité de la présence de davantage de chaînes de PEG à la surface des NPs faites de PEG-g-PLA que de NPS faites à partie de (PLA-PEG-PLA)n. Nos résultats démontrent que les propriétés des NPs peuvent être modifiées à la fois par le choix approprié de la composition en polymère mais aussi par l'architecture de ceux-ci. Les résultats suggèrent également que les copolymères de PEG-g-PLA pourraient être utilisés efficacement pour préparer des transporteurs nanométriques améliorant les propriétés de certains médicaments,notamment la solubilité, la stabilité et la biodisponibilité. / Biodegradable polymeric nanoparticles (NPs) have emerged as promising drug delivery carriers for the controlled drug release and targeting. The first part of this study aimed to develop biodegradable NPs from functionalized copolymers of poly (D,L-Lactide) (PLA). Those copolymers were explored as drug delivery systems in attempt to improve the drug delivery performance of conventional PLA NPs. The effect of PLA functionalization (insertion of chemical substituents onto PLA backbone) on the physicochemical properties of the obtained NPs was investigated. Moreover, the effect of polymer architecture (mode of organization of polymer chains in the resultant copolymer) on various drug delivery aspects was also studied. To reach those goals, various PLA based copolymers namely poly(ethylene glycol) (PEG) grafted on PLA backbone at 2.5% & 7% mol/mol of lactic acid monomers (PEG2.5%-g-PLA and PEG7%-g-PLA, respectively), palmitic acid grafted on PLA backbone at 2.5% grafting density (palmitic acid2.5%-g-PLA), and multiblock copolymer of PLA and PEG, (PLA-PEG-PLA)n were synthesized. In the second part, the effect of different PEG grafting densities over PLA backbone on the properties of PEG-g-PLA NPs either physicochemical or biological properties was investigated to reveal the optimal PEG grafting density required to develop stealth particles (long circulating NPs). Finally, functionalized PEG/PLA copolymers that showed the most satisfactory results in terms of various drug delivery aspects, such as size and size distribution, surface charge, drug loading, and controlled drug release were selected for encapsulation of itraconazole (ITZ) to improve its aqueous solubility, bioavailability and hence its antifungal activity. NPs were first prepared from functionalized PLA copolymers then analyzed for their major physicochemical parameters such as encapsulation efficiency, size and size distribution, surface charge, thermal properties, surface chemistry, % poly(vinyl alcohol) (PVA) adsorbed at the surface of NPs, and drug release pattern. Surface chemistry analysis using x-ray photoelectron spectroscopy (XPS), and atomic force microscopy (AFM) phase imaging were used to study the chain organization behavior of each functionalized copolymer during NPs formulation. Generally speaking, functionalized PEG/PLA copolymers showed improved drug delivery behavior in terms of narrow size and size distribution, enhanced loading efficiency, less plasma protein adsorption onto their surfaces and less macrophage uptake, and finally better antifungal activity for ITZ loaded NPs. For the surface chemistry analysis, AFM phase imaging and XPS studies revealed the possibility of existence of more PEG chains at the surface of PEG-g-PLA NPs than (PLA-PEG-PLA)n during NPs formation. Our results demonstrate that properties of PLA-based NPs can be tuned by proper selection of both polymer composition and polymer architecture. Results also suggest that PEG-g-PLA copolymers could be used efficiently as a nanocarrier to improve various drug properties e.g. solubility, stability, and bioavailability.

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal

No revestimento por solidificação de material fundido o agente de revestimento é aplicado em seu estado liquefeito e se solidifica na superfície do substrato, formando a cobertura desejada, eliminando o uso de solventes. O presente trabalho teve como objetivo estudar dois tipos de processo: revestimento de partículas grandes em leito de jorro e revestimento de partículas finas em leito fluidizado, e avaliar a influência de parâmetros do processo sobre propriedades físicas e farmacotécnicas das partículas revestidas, assim como usá-las no preparo de comprimidos. As partículas grandes foram revestidas com PEG 4000, sendo o estudo do processo feito através de um planejamento fatorial completo 23 com triplicatas no ponto central. As variáveis estudadas foram pressão do ar de atomização, vazão de atomização e altura do bico de atomização. Para as partículas revestidas foram determinados a distribuição granulométrica, o fator de Hausner e o índice de Carr. Os comprimidos destas partículas foram submetidos a ensaios de dissolução in vitro, para avaliação dos perfis de liberação de paracetamol. As partículas finas foram revestidas com uma dispersão sólida de PEG 4000 e curcumina, sendo o estudo do processo feito através de um planejamento fatorial completo 23, seguido de um planejamento Box-Behnken. As variáveis estudadas foram pressão do ar de atomização, vazão de atomização e quantidade de dispersão sólida. Para as partículas revestidas foram determinados a distribuição granulométrica, densidades aparente e compactada, fator de Hausner, capacidade de compactação, porosidade total, além de serem submetidas a microscopia eletrônica de varredura e a análise por DSC. A dispersão sólida também foi caracterizada através de análise por DSC, espectroscopia no infravermelho, difração de raios X, sendo também feita a determinação da solubilidade da curcumina em água. Os comprimidos destas partículas foram caracterizados através da obtenção do diagrama de Heckel, curvas de dureza em função da pressão de compressão aplicada e ensaio de dissolução in vitro. Para as partículas grandes, o estudo do processo sugeriu que a vazão de atomização foi o fator de maior influência sobre o tamanho das partículas, influenciando o grau de aglomeração durante o processo. Uma menor vazão de atomização resultou em um menor grau de aglomeração das partículas. A caracterização da dispersão sólida mostrou que houve um aumento da solubilidade da curcumina e que ela interage com PEG 4000. Para as partículas finas, o estudo do processo sugeriu que a pressão do ar de atomização foi fator de maior influência sobre o tamanho das partículas, sendo o seu revestimento favorecido quando se operou com o altos valores de pressão. Ambos os tipos de partículas revestidas resultaram em comprimidos com características adequadas. / The hot-melting coating is a solvent-free technique used to coat pharmaceutical solid dosage forms. The coating agent is applied in its melted state, and after its solidification, the coating is formed. The objective of this present work was to study two types of processes: coarse particle coating in spouted bed and fine particle coating in fluidized bed, evaluate the influence of process parameters on particle size and flow properties, as well as their tableting. Coarse particles were coated with PEG 4000, and the process study followed a full factorial design 23 with triplicates in the central point. The factors studied were atomization air pressure, atomization rate, and vertical position of the spray nozzle. Particle size distribution, Hausner factor and Carr index were determined for coated particles. Tablets of these particles were submitted to dissolution tests to obtain their release profile of paracetamol. Fine particles were coated with a solid dispersion of PEG 4000 and curcumin, in a study of the process that followed a full factorial design 23, and a Box-Behnken design. The factors studied were air atomization pressure, atomization rate, and the PEG 4000 content. Coated particles were characterized by their bulk and tapped densities, particle size distribution, Hausner factor, ability to settle, total porosity, scanning electron microscopy and DSC analysis. Solid dispersion was also characterized by DSC analysis, infrared spectroscopy, X-ray diffraction, being also made the determination of the curcumin solubility in water. Heckel´s plot, hardness as function of the applied pressure and in vitro dissolution tests were used to characterize the tablets. The study of the coating process of coarse particles suggested that the atomization rate was the most significant factor, influencing the particle agglomeration degree during the process. The lower the atomization rate, the lower the degree of particles agglomeration. Curcumin in the solid dispersion showed an increase in water solubility and also showed an interaction with PEG 4000 by hydrogen bounding. The study of the fine particles coating process showed that the atomization air pressure was the most significant factor on particle size. All tablets prepared from both types of coated particles showed adequate characteristics.

O câncer de mama constitui o segundo tipo de câncer mais frequente no mundo e o mais comum entre as mulheres, representando uma das principais causas de morte. O tamoxifeno é um fármaco antiestrogênico utilizado para o tratamento deste tipo de câncer desde 1971 e ainda é o mais utilizado nos casos de tumores mamários que expressam receptores de estrógeno. Apesar de apresentar resultados significativamente positivos, seu efeito antiestrogênico não se restringe apenas ao sítio tumoral causando, com isso, efeitos colaterais graves que podem deixar sequelas. A proposta deste trabalho foi desenvolver sistemas de liberação nanoparticulados à base de PLA e PLA-PEG para veiculação do tamoxifeno, como uma estratégia para o potencial aumento da segurança e da eficácia deste fármaco através de um possível direcionamento passivo ao sítio de ação, devido à permeabilidade vascular aumentada destas regiões tumorais. As nanopartículas foram preparadas pela técnica de nanoprecipitação e apresentaram diâmetro médio inferior a 200 nm para a maioria das formulações. Foram avaliados três estabilizantes, o poloxamer 407, o poloxamer 188 e o polissorbato 80, este último proporcionou maior eficiência de encapsulação, 86,7% e 100%, nas nanopartículas de PLA e PLA-PEG, respectivamente. Quanto à composição das nanopartículas de PLA-PEG, o polímero utilizado inicialmente (PLA(1000)-PEG(750)) apresentou distribuição de tamanho heterogênea, perfil multimodal e alto índice de polidispersividade. Assim, este polímero foi substituído pelo PLA(5000)-PEG(1000), que apresentou distribuição de tamanho uniforme, perfil monomodal e baixo índice de polidispersividade. A caracterização por microscopia eletrônica de varredura comprovou a homogeneidade no tamanho de partícula, mostrando seu formato esférico. As análises de espectrofotometria no infravermelho e calorimetria diferencial exploratória sugeriram que não ocorreu nenhum tipo de interação ou reação entre o fármaco e os demais componentes das formulações. Dois métodos analíticos para a determinação do tamoxifeno foram validados com sucesso por CLAE e espectroscopia UV-vis. O perfil de liberação in vitro do tamoxifeno a partir das nanopartículas de PLA apresentou característica sustentada e alcançou 50% em 180 h, tendo sido totalmente liberado após 288 h. Já as nanopartículas de PLA(5000)-PEG(1000) liberaram apenas 16,9% do fármaco após 216 h. A liberação do fármaco a partir das nanopartículas foi muito mais lenta comparada ao tamoxifeno não encapsulado, evidenciando a vantagem da incorporação do fármaco em nanopartículas compostas por PLA e PLA-PEG. No estudo do perfil de concentração plasmática em ratas Wistar, não foi possível detectar o fármaco e seu principal metabólito pelo método por CLAE desenvolvido, sugerindo que os sistemas nanoparticulados tenham extravasado rapidamente para os órgãos. / Breast cancer is the second most frequent type of cancer in the world and it is the most common among women, representing a major cause of death. Tamoxifen is an antiestrogen drug used in the treatment of this type of cancer since 1971 and it is the most employed drug in the treatment of breast cancer subtypes that expresses estrogen receptors. Despite presenting significantly positive results, its antiestrogen effect is not restricted to the tumour site, causing, as consequence, severe side effects. The purpose of this work was to develop nanostructured drug delivery systems based on PLA and PLA-PEG loaded with tamoxifen, as a strategy to potentially increase the safety and efficacy of this drug through a possible passive accumulation the site of action, due to the enhanced vascular permeability of tumour sites. Nanoparticles were prepared by the nanoprecipitation technique and presented average diameter smaller than 200 nm for the majority of the formulations. Three stabilizing adjuvants were analysed, poloxamer 407, poloxamer 188 and polysorbate 80 and the last one yielded the highest encapsulation efficiency, 86.7% and 100%, for the PLA and PLA-PEG nanoparticles, respectively. Regarding the PLA-PEG nanoparticles composition, the first polymer employed was (PLA(1000)-PEG(750)), which presented heterogeneous particle size distribution, multimodal profile and high polydispersity index. So, it was replaced by PLA(5000)-PEG(1000), which exhibited uniform particle size distribution, monomodal profile and low polydispersity index. The characterization by scanning electron microscopy confirmed the homogeneity of particles size, evidencing their spherical shape. Infrared spectrophotometry and differential scanning calorimetry analysis suggested that any interaction or reaction had occurred between the drug and the other components of the formulations. Two analytical methods for tamoxifen quantification were successfully validated by HPLC and UV-vis spectroscopy. In vitro tamoxifen release profile from PLA nanoparticles presented sustained release and reached 50% in 180 h, being completely released after 288 h, whereas PLA(5000)-PEG(1000) nanoparticles released only 16.9% of tamoxifen after 216 h. Drug release from nanoparticles was much slower compared to the non-encapsulated tamoxifen, showing the advantage of nanoparticles composed of PLA and PLA-PEG. In the plasmatic concentration profile study carried out in Wistar rats, it was not possible to detect tamoxifen or its main metabolite by the HPLC method, suggesting that nanoparticles quickly extravased to organs.

O câncer de mama é a segunda principal causa de morte entre as mulheres nos países em desenvolvimento, devido ao seu alto grau de malignidade. O tratamento baseia-se, principalmente, em terapias hormonais, uma vez que as células deste tipo de tumor expressam, em sua maioria, um elevado número de receptores hormonais, responsáveis pela regulação do crescimento do mesmo. O tamoxifeno é um fármaco da classe dos moduladores seletivos de receptores de estrógeno, que atua através do antagonismo à ativação de tais receptores por este hormônio, reduzindo, assim, a taxa de crescimento celular do tecido tumoral. Embora o tratamento com tamoxifeno seja altamente efetivo, este se relaciona a severos efeitos colaterais dosedependentes. O objetivo central deste trabalho foi desenvolver sistemas micelares de longo tempo de circulação contendo tamoxifeno, preparados à base do fosfolipídeo DSPE-PEG(n), associado ou não ao derivado de vitamina E TPGS, para administração intravenosa, capazes de permitir um acúmulo maior do fármaco no sítio tumoral devido a suas dimensões nanométricas, permitindo, desta forma, a redução da dose e a consequente redução dos efeitos colaterais. A determinação da eficiência de encapsulação e a quantificação do tamoxifeno no estudo de liberação in vitro a partir dos sistemas obtidos foram realizadas por CLAE, utilizando métodos previamente validados. Os melhores resultados foram alcançados com as formulações à base de DSPE-PEG(2000) e TPGS, preparadas pelo método de evaporação do solvente, as quais apresentaram diâmetro médio inferior a 20 nm, baixo índice de polidispersividade e eficiência de encapsulação entre 70 e 95%. A análise por microscopia eletrônica de transmissão evidenciou o formato esférico e comprovou a homogeneidade do tamanho das partículas. Os sistemas foram caracterizados, ainda, por espectrofotometria no infravermelho para avaliação de possíveis interações entre os componentes das formulações. O perfil de liberação in vitro demonstrou que após 168 h, no máximo cerca de 30% do fármaco foi liberado, verificando-se que o aumento na quantidade de TPGS na formulação reduziu a porcentagem de tamoxifeno liberado. A baixa taxa de liberação in vitro sugere que a maior parte do fármaco mantenha-se no interior da estrutura micelar durante o período de permanência no sangue, favorecendo a chegada da nanoestrutura íntegra ao sítio tumoral. No estudo do perfil de concentração plasmática em ratas Wistar, não foi possível detectar o fármaco e seu principal metabólito pelo método por CLAE desenvolvido, sugerindo que os sistemas micelares tenham extravasado rapidamente para os órgãos. / Breast cancer is the second main cause of death among women in development countries due to their high malignance grade. The treatment is mainly based on hormonal therapies, once the cells of the majority of mammary tumors express a high number of hormone receptors, responsible for the tumor growth. Tamoxifen is a selective estrogen receptor modulator drug, acting through the antagonism of the activation of the estrogen receptor, reducing thus the tumor growing rate. Despite the treatment with tamoxifen is highly effective, it is related to severe dose-dependent side effects. The central objective of this work was the development of long time circulation micelles containing tamoxifen, prepared with the phospholipid DSPEPEG(n) and TPGS, a vitamin E derivative, by the method of solvent evaporation, for intravenous administration, able to allow a higher accumulation of the drug at the tumoral site due to their nanometric dimensions, leading to a reduction in the dose and consequently in the side effects. The determination of the encapsulation efficiency and the quantification of tamoxifen in the in vitro release profile study from the micellar systems were carried out by HPLC, using methods previously validated. The best results were achieved with the formulations based on DSPE-PEG(2000) and TPGS, which showed mean particle diameter less than 20 nm, low polydispersity index and encapsulation efficiency ranging from 70 to 95%. The transmition electronic microscopy pointed the spherical shape and proved the homogeneity of particle size. The systems were also characterized by infrared spectrophotometry to identify eventual interactions among the components of the formulations. The in vitro release profile study showed that after 168 h, a maximum of about 30% of tamoxifen was released, evidencing that the increase of the TPGS amount in the formulation reduced the amount of tamoxifen released. The low rate of in vitro release drug suggests that the major part of the drug will remain encapsulated during the period of blood permanence, favoring the arrival of the intact nanostructure at the tumoral site. During the evaluation of the plasmatic concentration profile, conducted with Wistar rats, it was not possible to detect neither the tamoxifen nor its main metabolite, suggesting that the intact micelles may have quickly accumulated in the organs.

Ce travail de recherche est consacré à l’ingénierie d’un nouveau nanobiohybride à base de nanorubans de titanates pour la médecine régénérative. Dans un premier temps, les nanorubans ont été synthétisés par traitement hydrothermal et leurs caractéristiques morphologiques, structurales et chimiques ont été définies. Une caractérisation fine par différentes techniques de microscopie électronique à transmission a notamment permis de déterminer leur épaisseur; dimension qui n’avait encore jamais été mesurée. Par la suite, les nanorubans de titanates ont été fonctionnalisés par différents PEG hétérobifonctionnels préalablement synthétisés au laboratoire. Ces polymères présentent à l’une de leurs extrémités des groupements fonctionnels spécifiques pouvant se coupler à de nombreuses molécules biologiques. Des peptides de type collagène contenant des sites de reconnaissance cellulaire ont alors été greffés sur ces extrémités. Le nanobiohybride ainsi formé devra permettre l'adhésion et la prolifération des cellules favorisant in fine la cicatrisation et la régénération tissulaire. Pour évaluer les propriétés biologiques du nouveau nanobiohybride, la cytoxicité et le pouvoir agrégeant des nanorubans de titanes ont été déterminés par des tests MTT, réalisés sur deux populations de cellules (cardiomyocytes et fibroblastes) et par des tests d’agrégation plaquettaire (sang humain). Enfin, dans le cas d’une utilisation pour favoriser le processus de cicatrisation, le nouveau nanobiohybride a été formulé sous forme d’un hydrogel d’alginate de sodium permettant une application directe sur les tissus lésés. Pour confirmer l’intérêt de cette formulation galénique, des premiers tests in vivo ont été réalisés / This research work is devoted to new nanohybrid engineering composed of titanate nanoribbons for regenerative medicine. Over a first phase, nanoribbons were synthesized by hydrothermal treatment and their morphological, structural and chemical features were defined. A fine characterization by means of different techniques of transmission electron microscopy mainly enabled to determine their thickness; dimension which had never been measured so far. Subsequently, titanate nanoribbons were functionalized by different home-made heterobifunctional PEG. Those polymers present at one of their extremities specific functional groups being able to couple with numerous biological molecules. Some collagen type peptides containing cellular recognition sites were grafted onto those extremities. The so-formed nanobiohybrid will permit cellular adhesion and proliferation favouring in fine tissue healing and regeneration. To evaluate new nanohybrid biological properties, titanate nanoribbons cytoxicity and aggregating power were determined by MTT tests, performed on two cell populations (fibroblasts and cardiomyocytes) and platelet aggregation tests (human blood). Finally, when used to promote healing process, the new nanobiohybrid was formulated in the form of sodium alginate hydrogel permitting a direct application on damaged tissues. To confirm the interest of this galenic form, initial in vivo tests were realized